ATE372375T1 - Für den bradykinin-b1-rezeptor kodierende dna - Google Patents

Für den bradykinin-b1-rezeptor kodierende dna

Info

Publication number
ATE372375T1
ATE372375T1 AT95916317T AT95916317T ATE372375T1 AT E372375 T1 ATE372375 T1 AT E372375T1 AT 95916317 T AT95916317 T AT 95916317T AT 95916317 T AT95916317 T AT 95916317T AT E372375 T1 ATE372375 T1 AT E372375T1
Authority
AT
Austria
Prior art keywords
receptor
bradykinin
recombinant
dna coding
host cells
Prior art date
Application number
AT95916317T
Other languages
English (en)
Inventor
David L Linemeyer
John W Hess
Joseph A Borkowski
Kathleen K Bierilo
John G Menke
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22861167&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE372375(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE372375T1 publication Critical patent/ATE372375T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72Receptors; Cell surface antigens; Cell surface determinants for hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT95916317T 1994-04-15 1995-04-10 Für den bradykinin-b1-rezeptor kodierende dna ATE372375T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/229,418 US5712111A (en) 1994-04-15 1994-04-15 DNA encoding bradykinin B1 receptor

Publications (1)

Publication Number Publication Date
ATE372375T1 true ATE372375T1 (de) 2007-09-15

Family

ID=22861167

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95916317T ATE372375T1 (de) 1994-04-15 1995-04-10 Für den bradykinin-b1-rezeptor kodierende dna

Country Status (8)

Country Link
US (4) US5712111A (de)
EP (1) EP0757716B1 (de)
JP (1) JP2001506481A (de)
AT (1) ATE372375T1 (de)
CA (1) CA2187740C (de)
DE (1) DE69535590T2 (de)
ES (1) ES2292168T3 (de)
WO (1) WO1995028474A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712111A (en) * 1994-04-15 1998-01-27 Merck & Co., Inc. DNA encoding bradykinin B1 receptor
SE9602822D0 (sv) * 1996-07-19 1996-07-19 Astra Pharma Inc New receptor
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6469150B1 (en) * 2000-05-22 2002-10-22 Pharmacopeia, Inc. Cloning and characterization of genes encoding bradykinin B1 receptor homologues from five mammalian species
JP2005502341A (ja) * 2001-08-20 2005-01-27 メルク エンド カムパニー インコーポレーテッド B1ブラジキニン受容体タンパク質を調節するための動物モデルとしてのトランスジェニックげっ歯類
JP2007508814A (ja) * 2003-10-08 2007-04-12 メルク エンド カムパニー インコーポレーテッド ヒトb1ブラジキニン受容体タンパク質を選択的に発現するトランスジェニックげっ歯動物
JP2008539260A (ja) * 2005-04-25 2008-11-13 アムジエン・インコーポレーテツド ポロゲンを含む生分解性プチド徐放性組成物
BR112013013674A2 (pt) * 2010-12-03 2016-09-06 Diamedica Inc anticorpo monoclonal de receptor anti-bradicinina b2 (bkb2r)
WO2013173923A1 (en) 2012-05-25 2013-11-28 Diamedica, Inc. Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
EP2854841B1 (de) 2012-06-04 2017-02-22 Diamedica Inc. Kallikrein-1-glycosylierungsisoformen aus menschlichem gewebe
AU2018230478B2 (en) 2017-03-09 2025-01-23 Diamedica Inc. Dosage forms of tissue kallikrein 1

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712111A (en) * 1994-04-15 1998-01-27 Merck & Co., Inc. DNA encoding bradykinin B1 receptor

Also Published As

Publication number Publication date
EP0757716A4 (de) 1999-07-21
EP0757716A1 (de) 1997-02-12
WO1995028474A1 (en) 1995-10-26
CA2187740A1 (en) 1995-10-26
US5712111A (en) 1998-01-27
US5965367A (en) 1999-10-12
DE69535590D1 (de) 2007-10-18
JP2001506481A (ja) 2001-05-22
CA2187740C (en) 2010-06-29
EP0757716B1 (de) 2007-09-05
ES2292168T3 (es) 2008-03-01
US20030036633A1 (en) 2003-02-20
US6307027B1 (en) 2001-10-23
DE69535590T2 (de) 2008-05-29

Similar Documents

Publication Publication Date Title
DE69633825D1 (de) Modifiziertes enzym mit lipolytischer aktivität
ATE310098T1 (de) Dna kodierend für glutaminsäure-gesteuerte chloridkanäle
ATE372375T1 (de) Für den bradykinin-b1-rezeptor kodierende dna
ATE404583T1 (de) Funktionelle antagonisten von hedgehog-aktivität
IL193919A0 (en) DcR3 POLYPEPTIDE A TNFR HOMOLOG
MXPA04002808A (es) Acidos nucleicos receptores de ecdisona de mosca blanca, polipeptidos, y sus usos.
FI972390A0 (fi) Sytokiini nimeltä Lerk-7
EP0998569A4 (de) Polynukleotid kodierend für ein polypeptid mit heparanase-aktivität und dessen expression in transduzierten zellen
ATE319818T1 (de) Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren
ATE414775T1 (de) Polypeptide mit prolyldipeptidylaminopeptidase- aktivität und dafür kodierende nukleinsäuren
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
ATE233788T1 (de) Interleukin-15-rezeptoren
ATE384787T1 (de) Tripeptidyl-aminopeptidase
IL109090A0 (en) Ptp-s31: a novel protein tyrosine phosphatase
DE69837475D1 (de) Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren
DE69533044D1 (de) FÜR DEN TYP II-MORPHOGENETISCHEN-KNOCHENPROTEIN-REZEPTOR KODIERENDE cDNS
CA2032167A1 (en) Dna coding for protein binds to enhancer of.alpha.-fetoprotein gene
DE60033297D1 (de) Für die humane untereinheit 5-ht3-c des serotoninrezeptors 5-ht3 kodierende dna
ES8700051A1 (es) Un procedimiento para preparar una composicion oral estable,formadora de espuma
DE59814002D1 (de) Sekretion von tragergebundenen proteinen in das periplasma und in den extrazellulären raum
DE60132571D1 (de) Für den menschlichen vanilloid-rezeptor vr3 kodierende dns
HUP9801330A2 (hu) Új PKA-kötő fehérjék és alkalmazásuk
FR2697850B1 (fr) Nouveaux polypeptides ayant une activité de récepteur opioïde, acides nucléiques codant pour ces polypeptides et utilisations.
DE59611293D1 (de) Protein mit dnase-aktivität
FR2722209B1 (fr) Recepteur opioide kappa humain, acides nucleiques et utilisations

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties